| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |